Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Percutaneous sacral neurostimulation of penile erection during radical prostatectomy: surgical technique.

Translational andrology and urology·2026
Same author

Periprocedural anti-thrombotic therapy and priapism recurrence after surgical shunting: a propensity-matched analysis.

The journal of sexual medicine·2026
Same author

Predicting major ischemic priapism: a novel dynamic nomogram based on recurrent ischemic priapism risk factors.

The journal of sexual medicine·2026
Same author

Changes in sexual quality of life in patients with stress urinary incontinence treated with an artificial urinary sphincter; analysis of the artificial urinary sphincter clinical outcomes trial (AUSCO).

The journal of sexual medicine·2026
Same author

Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial.

JAMA internal medicine·2026
Same author

Safety and tolerability of a novel implantable neurostimulator to improve erectile function: a pilot study in patients with spinal cord injury.

The journal of sexual medicine·2026

Related Experiment Video

Updated: May 30, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Erectile preservation following radical prostatectomy.

Robert Segal1, Arthur L Burnett

  • 1Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

Therapeutic Advances in Urology
|July 27, 2011
PubMed
Summary

Radical prostatectomy can cause erectile dysfunction (ED). This review covers treatments like PDE5 inhibitors and penile prostheses, and discusses their role in ED treatment and penile rehabilitation.

Keywords:
erectile dysfunctionpenile rehabilitationprostate cancerradical prostatectomy

More Related Videos

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

Related Experiment Videos

Last Updated: May 30, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

Area of Science:

  • Urology
  • Oncology
  • Men's Health

Background:

  • Prostate cancer is the most common male cancer, often treated with radical prostatectomy.
  • Radical prostatectomy can lead to significant erectile dysfunction (ED), impacting quality of life.
  • Post-prostatectomy ED has multiple causes, including arteriogenic, venogenic, and neurogenic factors, and may increase Peyronie's disease risk.

Purpose of the Study:

  • To review current and novel treatment options for post-prostatectomy erectile dysfunction.
  • To discuss the role of various therapies in both ED treatment and penile rehabilitation.
  • To highlight areas where further research is needed, particularly for penile rehabilitation protocols.

Main Methods:

  • Comprehensive literature review using the PubMed database.
  • Selection of articles based on topical relevance, methodology, and findings.
  • Assessment of data supporting therapeutic options for ED treatment and rehabilitation.

Main Results:

  • Multiple therapeutic options exist for post-prostatectomy ED, including PDE5 inhibitors, intracavernosal injections, intraurethral alprostadil, vacuum erection devices, and penile prostheses.
  • Evidence supports the use of these therapies for both treating ED and aiding penile rehabilitation.
  • Novel therapies are also under review for potential future applications.

Conclusions:

  • Current treatments offer viable options for managing post-prostatectomy ED and supporting penile rehabilitation.
  • Further research is essential to confirm the benefits of penile rehabilitation and establish optimal protocols.
  • A multi-faceted approach combining treatment and rehabilitation may be key to improving patient outcomes.